Systemic administration of insulin-like growth factor decreases motor neuron cell death and promotes muscle reinnervation

J Neurosci Res. 1998 Dec 15;54(6):840-7. doi: 10.1002/(SICI)1097-4547(19981215)54:6<840::AID-JNR12>3.0.CO;2-L.

Abstract

Neonatal sciatic nerve axotomy causes motoneuron death and muscle denervation atrophy. The aim of the present study was to determine whether insulin-like growth factor-I (IGF-I) administration promotes muscle reinnervation and counteracts motor neuron loss after such an injury. Six weeks after sciatic nerve axotomy performed in 2-day-old pups, the number of motor neurons, as assessed by retrograde transport of horseradish peroxidase injected into the extensor digitorum longus (EDL) muscle, was reduced from 52 +/- 3 to 26 +/- 3. Subsequent administration of IGF-I at the doses of 0.02 mg/kg or 1 mg/kg increased the number of motor neurons to 35 +/- 2 and 37 +/- 5, respectively. The effect on motoneuron survival was accompanied by improved muscle fibre morphometry and restoration of indirect EDL muscle isometric twitch tension, which was about 80 % of control values for both doses of IGF-I compared with 60% observed with saline treatment. Reinnervated EDL muscle from saline-treated rats cannot hold tetanic tension, which is, however, achieved after IGF-I treatment at either dose. Thus, both high and low doses of IGF-I counteracted motoneuron death and improved muscle reinnervation following neonatal sciatic nerve axotomy. IGF-I at 5 microg/kg failed to increase muscle reinnervation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Death / drug effects*
  • Insulin-Like Growth Factor I / administration & dosage
  • Insulin-Like Growth Factor I / pharmacology*
  • Motor Neurons / drug effects*
  • Motor Neurons / physiology
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / innervation*
  • Muscular Atrophy / etiology
  • Nerve Crush
  • Nerve Regeneration* / drug effects
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Insulin-Like Growth Factor I

Grants and funding